The Andrews Labor Government is backing Victorian research into new coronavirus treatment, including a nasal spray medication that envelops the virus and reduces household transmission.
Acting Minister for Innovation, Medical Research and the Digital Economy Mary-Anne Thomas today announced $13.3 million in grants for seven research projects examining a range of coronavirus treatment options.
University of Melbourne and Monash University have received $4.2 million to establish a six-month clinical trial, developed in collaboration with Oxford University, of a heparin-based nasal spray to be used in households where a person has coronavirus.
The second most widely used drug in the world and primarily prescribed as a blood-thinner to treat or prevent blood clots, heparin forms the base of the nasal spray treatment which is already being hailed as a success for its easy administration, stability at room temperature and global availability.
The IntraNasal HEpaRin Trial (INHERIT) will be led by the Northern Hospital, using the Covid (Oximetry) Monitoring and Early Treatment (COMET) platform that has enabled researchers to access and treat patients within 24 hours of their diagnosis, speeding up treatment and providing remote patient monitoring through portable oximeter devices that measure oxygen levels in blood.
Other research projects receiving funding include $2 million for a Walter and Eliza Hall Institute trial of antiviral cocktails for immunocompromised patients unable to receive coronavirus vaccines, and $1.8 million for a Burnet Institute study on a suite of biological medications that could neutralise and kill virus-infected cells. For the full list, go to djpr.vic.gov.au/medical-
In the past year, the Labor Government has invested more than $590 million in medical research—including up to $400 million for a new Australian Institute of Infectious Disease to lead the fight against future pandemics. Clinical trials held in Victoria contribute more than $300 million annually to the state’s economy.
Last week, Victorian scientists and manufacturers reached a major milestone, unveiling Australia’s first mRNA COVID-19 vaccine candidate after a research period of just five months. Clinical trials will commence in early 2022.
Follow The Indian Sun on Twitter | Instagram | Facebook
The Andrews Labor Govt is backing Victorian research into new #coronavirus treatment, including a #nasalspray medication that envelops the virus and reduces household transmission. #TheIndianSunhttps://t.co/SwGvFyWGq8
— The Indian Sun (@The_Indian_Sun) December 23, 2021
Donate To The Indian Sun
Dear Reader,The Indian Sun is an independent organisation committed to community journalism. We have, through the years, been able to reach a wide audience especially with the growth of social media, where we also have a strong presence. With platforms such as YouTube videos, we have been able to engage in different forms of storytelling. However, the past few years, like many media organisations around the world, it has not been an easy path. We have a greater challenge. We believe community journalism is very important for a multicultural country like Australia. We’re not able to do everything, but we aim for some of the most interesting stories and journalism of quality. We call upon readers like you to support us and make any contribution. Do make a DONATION NOW so we can continue with the volume and quality journalism that we are able to practice.
Thank you for your support.
Best wishes,
Team The Indian Sun
